posted on 2021-02-26, 04:31authored byAmi A. Shah, Takeru Igusa, Daniel Goldman, Jessica Li, Livia Casciola-Rosen, Antony Rosen, Michelle Petri
Additional file 1: Supplemental Table 1. SLE characteristics by cancer status. Supplemental Table 2. Laboratory parameters and serologies by cancer status. Supplemental Table 3. Drug exposure (ever use) by cancer status. Supplemental Table 4. Cancer sites observed in the Hopkins Lupus Cohort (N = 119 cancer cases).
Funding
National Institute of Arthritis and Musculoskeletal and Skin Diseases